We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

Cancer cell | Aug 5, 2003

MLL is a histone methyltransferase that can be converted into an oncoprotein by acquisition of transcriptional effector domains following heterologous protein fusions with a variety of nuclear transcription factors, cofactors, or chromatin remodeling proteins in acute leukemias. Here we demonstrate an alternative mechanism for activation of MLL following fusions with proteins (AF1p/Eps15 and GAS7) that normally reside in the cytoplasm. The coiled-coil oligomerization domains of these proteins are necessary and sufficient for leukemogenic transformation induced by the respective MLL fusion proteins. Furthermore, homodimerization of MLL by synthetic dimerization modules mimics bona fide MLL fusion proteins resulting in Hox gene activation and enhanced self-renewal of hematopoietic progenitors. Our studies support an oligomerization-dependent mechanism for oncogenic conversion of MLL, presumably in part by recruitment of accessory factors through the dimerized MLL moiety of the chimeric protein.

Pubmed ID: 12957285 RIS Download

Mesh terms: Acute Disease | Adaptor Proteins, Signal Transducing | Animals | COS Cells | Calcium-Binding Proteins | Cell Line | Cell Transformation, Neoplastic | Cercopithecus aethiops | DNA-Binding Proteins | Dimerization | Gene Expression Regulation, Neoplastic | Histone-Lysine N-Methyltransferase | Homeodomain Proteins | Humans | Intracellular Signaling Peptides and Proteins | Leukemia | Methyltransferases | Mice | Mice, Inbred C57BL | Myeloid-Lymphoid Leukemia Protein | Nerve Tissue Proteins | Phosphoproteins | Protein Methyltransferases | Protein Structure, Tertiary | Proto-Oncogenes | Recombinant Fusion Proteins | Survival Rate | Trans-Activators | Transcription Factors | Transcriptional Activation

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.